State Street SPDR S&P Biotech ETF
XBIDividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| December 24, 2025 | $0.41 | 2025-12-22 | 2025-12-22 |
| September 24, 2025 | $0.03 | 2025-09-22 | 2025-09-22 |
| June 25, 2025 | $0.01 | 2025-06-23 | 2025-06-23 |
| March 26, 2025 | $0.01 | 2025-03-24 | 2025-03-24 |
| December 26, 2024 | $0.00 | 2024-12-23 | 2024-12-23 |
Dividends Summary
- Consistent Payer: State Street SPDR S&P Biotech ETF has rewarded shareholders with 46 dividend payments over the past 18 years.
- Total Returned Value: Investors who held XBI shares during this period received a total of $5.77 per share in dividend income.
- Latest Payout: The most recent dividend of $0.41/share was paid 30 days ago, on December 24, 2025.
- Yield & Schedule: XBI currently pays dividends quarterly with an annual yield of 0.34%.
- Dividend Growth: Since 2007, the dividend payout has grown by 197.7%, from $0.14 to $0.41.
- Growth Streak: XBI has raised its dividend for 5 consecutive payments.
Company News
The biotech sector is showing signs of stabilization with increasing venture capital funding and family office investments. Experts suggest careful selection of biotech companies with strong science, sufficient capital, and near-market products.
Bank of America's chief investment strategist Michael Hartnett recommends buying long-duration bonds as yields stabilize and the potential for lower government deficits under the Trump administration. He suggests four ETFs to watch: iShares 20+ Year Treasury Bond ETF (TLT), SPDR S&P Biotech ETF (XBI), SPDR Homebuilders ETF (XHB), and SPDR Utiliti...
The biotech industry has lagged the broader market in 2024, but CRISPR Therapeutics and Exelixis still look like solid long-term picks. CRISPR Therapeutics has a promising gene-editing therapy, while Exelixis' cancer drug Cabometyx continues to drive strong financial results.
The biotech sector's breakout attempt post-election reversed sharply, with ETFs like IBB and XBI falling and invalidating the long-term bullish setup. The appointment of RFK Jr. to lead the Department of Health and Human Services has spooked investors with his controversial policies and vaccine skepticism, leading to a decline in sector giants li...
The article discusses 8 technical charts that suggest the stock market could see a deeper pullback in the near-term, including signs of a potential island reversal top in the S&P 500, a diamond top or head and shoulders pattern in the Nasdaq 100, and weakness in high-yield bonds and biotech stocks.
